000 01264 a2200349 4500
005 20250512012740.0
264 0 _c19890821
008 198908s 0 0 eng d
022 _a0278-5846
024 7 _a10.1016/0278-5846(89)90013-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOmérov, M
245 0 0 _aThe relationship between perphenazine plasma levels and clinical response in acute schizophrenia.
_h[electronic resource]
260 _bProgress in neuro-psychopharmacology & biological psychiatry
_c1989
300 _a159-66 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
650 0 4 _aAdult
650 0 4 _aClinical Trials as Topic
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPerphenazine
_xadverse effects
650 0 4 _aSchizophrenia
_xblood
700 1 _aWistedt, B
700 1 _aBolvig-Hansen, L
700 1 _aLarsen, N E
773 0 _tProgress in neuro-psychopharmacology & biological psychiatry
_gvol. 13
_gno. 1-2
_gp. 159-66
856 4 0 _uhttps://doi.org/10.1016/0278-5846(89)90013-4
_zAvailable from publisher's website
999 _c2670776
_d2670776